A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status:
Terminated
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Phosphatidylcholine (LT-02) add on
treatment is effective and safe for the induction of remission in ulcerative colitis patients
refractory to standard treatment with mesalamine